References
[1] G.A. Stevens, R.A. White, S.R. Flaxman, H. Price, J.B. Jonas, J. Keeffe, J. Leasher, K. Naidoo, K. Pesudovs, S. Resnikoff, H. Taylor, R. Bourne, Global prevalence of vision impairment and blindness: magnitude and temporal trends, 1990–2010, Ophthalmology, 120 (12) (2013) 2377–2384.
[2] N. Bodor, P. Buchwald, Ophthalmic drug design based on the metabolic activity of the eye: soft drugs and chemical delivery systems, AAPS J., 7 (4) (2005) E820–E833.
[3] M.C. Coroi, S. Bungau, M. Tit, Preservatives from the eye drops and the ocular surface, Rom. J. Ophthalmol., 59 (1) (2015) 2–5.
[4] P. Baranowski, B. Karolewicz, M. Gajda, J. Pluta, Ophthalmic drug dosage forms: characterisation and research methods, Sci. World J., 2014 (2014) 1–14.
[5] A. Yeung, N.T. Tzvetkov, O.S. El-Tawil, S.G. Bungǎu, M.M. Abdel-Daim, A. G. Atanasov, Antioxidants: scientific literature landscape analysis, Oxid. Med. Cell. Longev., 2019 (2019) 1–11.
[6] Y. Li, J. Yao, C. Han, J. Yang, M.T. Chaudhry, S. Wang, H. Liu, Y. Yin, Quercetin, inflammation and immunity, Nutrients, 8 (3) (2016) 167.
[7] R.V. Patel, B.M. Mistry, S.K. Shinde, R. Syed, V. Singh, H.S. Shin, Therapeutic potential of quercetin as a cardiovascular agent, Eur. J. Med. Chem., 155 (2018) 889–904.
[8] X.J. Wu, X.B. Zhou, C. Chen, W. Mao, Systematic investigation of quercetin for treating cardiovascular disease based on network pharmacology, Comb. Chem. High Throughput Screen., 22 (6) (2019) 411–420.
[9] J.S. Nam, A.R. Sharma, L.T. Nguyen, C. Chakraborty, G. Sharma, S.S. Lee, Application of bioactive quercetin in oncotherapy: from nutrition to nanomedicine, Molecules, 21 (1) (2016) 108.
[10] L.G. Costa, J.M. Garrick, P.J. Roqu`e, C. Pellacani, Mechanisms of neuroprotection by quercetin: counteracting oxidative stress and more, Oxid. Med. Cell. Longev., 2016 (2016) 1–10.
[11] T.B. McKay, D. Karamichos, Quercetin and the ocular surface: what we know and where we are going, Exp. Biol. Med., 242 (6) (2017) 565–572.
[12] T. Hirano, M. Kawai, J. Arimitsu, M. Ogawa, Y. Kuwahara, K. Hagihara, Y. Shima, M. Narazaki, A. Ogata, M. Koyanagi, Preventative effect of a flavonoid, enzymatically modified isoquercitrin on ocular symptoms of Japanese cedar pollinosis, Allergol. Int., 58 (3) (2009) 373–382.
[13] T.B. McKay, D. Lyon, A. Sarker-Nag, S. Priyadarsini, J.M. Asara, D. Karamichos, Quercetin attenuates lactate production and extracellular matrix secretion in keratoconus, Sci. Rep., 5 (2015) 9003.
[14] J.S. Yoon, H.J. Lee, S.H. Choi, E.J. Chang, S.Y. Lee, E.J. Lee, Quercetin inhibits IL- 1β-induced inflammation, hyaluronan production and adipogenesis in orbital fibroblasts from Graves’ orbitopathy, PLoS One, 6 (10) (2011), e26261.
[15] W. Song, X. Zhao, J. Xu, H. Zhang, Quercetin inhibits angiogenesis-mediated human retinoblastoma growth by targeting vascular endothelial growth factor receptor, Oncol. Lett., 14 (3) (2017) 3343–3348.
)
)